Alamar Biosciences (ALMR) vs 10x Genomics (TXG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
10x Genomics is the larger company by market cap ($10.07 billion vs $1.80 billion), about 5.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | TXG |
|---|---|---|
| Share price | $25.91 | $77.28 |
| Market cap | $1.80B | $10.07B |
| 1-day change | -6.70% | +1.55% |
| YTD return | — | +366.58% |
| 1-year return | — | +556.03% |
| 5-year return | — | -50.02% |
| EPS (TTM) | $-1.20 | $-0.59 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $642.82M |
| Revenue growth (YoY) | — | +5.25% |
| Net income (latest FY) | — | $-43.54M |
| Gross margin | — | 69.05% |
| Operating margin | — | -9.49% |
| Net margin | — | -6.77% |
| 52-week high | $39.61 | $102.81 |
| 52-week low | $18.85 | $11.16 |
| Distance from 52-week high | -34.59% | -24.83% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +36.63% | -12.69% |
| Average volume | 399.23K | 3.25M |
| Shares outstanding | 69.39M | 120.21M |
| Employees | 286 | 1,178 |
| Sector | Industrials | Healthcare |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- 10x Genomics is about 5.6 times larger than Alamar Biosciences by market value ($10.07B vs $1.80B).
- The two companies sit in different sectors: Alamar Biosciences in Industrials and 10x Genomics in Healthcare.
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About 10x Genomics
TXG stock →10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
Healthcare · Medical Devices · 1,178 employees
ALMR vs TXG FAQ
Which is bigger, Alamar Biosciences or 10x Genomics?
10x Genomics (TXG) is larger, with a market capitalization of $10.07B compared with $1.80B for Alamar Biosciences (ALMR).
Are Alamar Biosciences and 10x Genomics in the same industry?
No. Alamar Biosciences is in the Industrials sector, while 10x Genomics is in Healthcare.